Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia ABusiness Wire • 06/13/22
Charles River Labs stock slides 6% premarket after company issues profit warning for Q2Market Watch • 06/08/22
Charles River Laboratories to Participate in Jefferies and William Blair ConferencesBusiness Wire • 06/06/22
Charles River Laboratories International, Inc. (CRL) CEO James Foster on Q1 2022 Earnings Call TranscriptSeeking Alpha • 05/04/22
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical AssetsBusiness Wire • 04/27/22
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference CallBusiness Wire • 04/13/22
Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial OfficerBusiness Wire • 03/28/22
Charles River Laboratories International, Inc. (CRL) CEO James Foster on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/17/22